Scientific Reports · 2017 · 38 citations · 62 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntibody ConjugatesAntibody ConjugationCancer ImmunotherapyCancer VaccinesConjugate VaccinesVaccine Antigen DiscoveryCancer Vaccine DesignCancer Vaccine ImmunologyConjugate CharacterizationConjugate Vaccine AdjuvantsImmunological ResponseSynthetic AdjuvantsTherapeutic Cancer ImmunizationTumor Antigen Vaccines
An efficient method was developed for the synthesis of a GM2 derivative suitable for the conjugation with various biomolecules. This GM2 derivative was covalently linked to keyhole limpet hemocyanin (KLH) and monophosphoryl lipid A (MPLA) to form novel therapeutic cancer vaccines. Immunological evaluations of the resultant conjugates in mice revealed that they elicited robust GM2-specific overall and IgG antibody responses. Moreover, the GM2-MPLA conjugate was disclosed to elicit strong immune responses without the use of an adjuvant, proving its self-adjuvant property. The antisera of both conjugates showed strong binding and mediated similarly effective complement-dependent cytotoxicity to GM2-expressing cancer cell line MCF-7. Based on these results, it was concluded that both GM2-MPLA and GM2-KLH are promising candidates as therapeutic cancer vaccines, whereas fully synthetic GM2-MPLA, which has homogeneous and well-defined structure and self-adjuvant property, deserves more attention and studies.
62
Quantitive estimation of sialic acids
Lars Svennerholm · Biochimica et Biophysica Acta · 1957 · 2.8K citations
Possible roles of tumor-associated carbohydrate antigens.
Minoru Fukuda · PubMed · 1996 · 421 citations
Life Sciences, Immunology, Oncology +17